Legal & General Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,179,950
| Closed | -$415M | – | 3422 |
|
|
2019
Q3 | $415M | Sell |
4,179,950
-8,115
| -0.2% | -$771K | 0.22% | 98 |
|
|
2019
Q2 | $387M | Sell |
4,188,065
-119,362
| -3% | -$11.3M | 0.21% | 104 |
|
|
2019
Q1 | $406M | Buy |
4,307,427
+790,907
| +22% | +$69.2M | 0.23% | 95 |
|
|
2018
Q4 | $225M | Buy |
3,516,520
+209,564
| +6% | +$15.5M | 0.17% | 131 |
|
|
2018
Q3 | $296M | Buy |
3,306,956
+3,858
| +0.1% | +$341K | 0.21% | 106 |
|
|
2018
Q2 | $262M | Sell |
3,303,098
-249,341
| -7% | -$20.7M | 0.2% | 115 |
|
|
2018
Q1 | $317M | Sell |
3,552,439
-191,813
| -5% | -$18.4M | 0.24% | 87 |
|
|
2017
Q4 | $391M | Sell |
3,744,252
-84,127
| -2% | -$9.49M | 0.28% | 76 |
|
|
2017
Q3 | $558M | Buy |
3,828,379
+76,872
| +2% | +$10.5M | 0.42% | 44 |
|
|
2017
Q2 | $487M | Buy |
3,751,507
+163,884
| +5% | +$20.1M | 0.39% | 45 |
|
|
2017
Q1 | $446M | Buy |
3,587,623
+147,263
| +4% | +$17.6M | 0.38% | 46 |
|
|
2016
Q4 | $398M | Buy |
3,440,360
+89,230
| +3% | +$9.94M | 0.37% | 51 |
|
|
2016
Q3 | $350M | Buy |
3,351,130
+32,068
| +1% | +$3.47M | 0.35% | 55 |
|
|
2016
Q2 | $327M | Sell |
3,319,062
-6,098
| -0.2% | -$631K | 0.34% | 59 |
|
|
2016
Q1 | $333M | Buy |
3,325,160
+46,095
| +1% | +$4.75M | 0.37% | 55 |
|
|
2015
Q4 | $393M | Buy |
3,279,065
+63,373
| +2% | +$7.33M | 0.44% | 45 |
|
|
2015
Q3 | $348M | Buy |
3,215,692
+88,835
| +3% | +$11M | 0.42% | 47 |
|
|
2015
Q2 | $362M | Buy |
3,126,857
+28,636
| +0.9% | +$3.27M | 0.43% | 50 |
|
|
2015
Q1 | $357M | Sell |
3,098,221
-55,549
| -2% | -$6.64M | 0.43% | 48 |
|
|
2014
Q4 | $353M | Sell |
3,153,770
-95,750
| -3% | -$10.1M | 0.42% | 48 |
|
|
2014
Q3 | $308M | Sell |
3,249,520
-128,665
| -4% | -$11.6M | 0.37% | 57 |
|
|
2014
Q2 | $290M | Sell |
3,378,185
-32,661
| -1% | -$2.48M | 0.34% | 66 |
|
|
2014
Q1 | $238M | Sell |
3,410,846
-108,274
| -3% | -$8.57M | 0.29% | 80 |
|
|
2013
Q4 | $297M | Sell |
3,519,120
-27,032
| -0.8% | -$2.14M | 0.36% | 59 |
|
|
2013
Q3 | $273M | Sell |
3,546,152
-93,840
| -3% | -$6.58M | 0.36% | 62 |
|
|
2013
Q2 | $213M | Buy |
+3,639,992
| New | +$219M | 0.29% | 78 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Legal & General Group's CELG Position: Q4 2019 in Review
Legal & General Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,179,950 shares — an estimated $415M sold.
Legal & General Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $558M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Legal & General Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Legal & General Group sold 4,179,950 Celgene Corp shares in Q4 2019, an estimated $415M.
- Legal & General Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Legal & General Group's Celgene Corp position peaked at $558M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.